Latest stories on ABSI
Absci Sinks 8%, Schrödinger and Recursion Slide as AI Drug Discovery Stocks Give Back Rally
Yahoo Finance38 · neutralgeneral
Absci initiated with a Buy at Jefferies
The Fly63 · neutralanalyst
Jefferies initiates Absci stock with buy on hair loss drug potential
Investing.com Analyst Ratings64 · neutralanalyst
Absci to Participate in Upcoming Investor Conferences
GlobeNewswire53 · neutralproduct/pr
Absci to Participate in Upcoming Investor Conferences
Business Insider53 · neutralproduct/pr
ABSI Spotlight: Interim Phase 1 Signals Put Absci’s ABS-201 Hair-Loss Program on a 2H 2026 Proof-of-Concept Clock
October 22, 2026
MarketChameleon58 · neutralproduct/pr
Absci’s AI Antibody Push Meets a New Bottleneck: Immune-Risk Screening Is Finally Scaling
October 21, 2026
MarketChameleon63 · neutralproduct/pr
Absci price target raised to $20 from $16 at KeyBanc
The Fly64 · neutralanalyst
Absci highlights an estimated 65-day-plus half-life for ABS-201 as AI-designed biologics shift from design to lab proof
October 15, 2026
MarketChameleon64 · neutralproduct/pr
Absci Sets November 12 Call for Q3 2026 Results, Spotlighting Its Generative AI Drug-Creation Platform
October 13, 2026
MarketChameleon53 · neutralproduct/pr
Absci to Report Business Updates and Third Quarter 2026 Financial and Operating Results on November 12, 2026
Business Insider50 · neutralearnings
Absci to Report Business Updates and Third Quarter 2026 Financial and Operating Results on November 12, 2026
GlobeNewswire50 · neutralearnings
Absci price target raised to $15 from $14 at JPMorgan
The Fly63 · neutralanalyst
Absci Announces Preliminary Details for Phase 2 STORYLINE™ Trial of AI-Designed Antibody ABS-201™ for Endometriosis
StockTitan59 · neutralproduct/pr
Absci Announces Preliminary Details for Phase 2 STORYLINE™ Trial of AI-Designed Antibody ABS-201™ for Endometriosis
GlobeNewswire59 · neutralproduct/pr
Absci Corporation (ABSI) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Seeking Alpha56 · neutralgeneral
Baldness Drug Stocks like Veradermics (MANE) and Absci (ABSI) Are Chasing the Same Wall Street Magic as Ozempic
Yahoo Finance73 · bullishproduct/pr
Absci's Billion-Dollar Hair Bet: Why The AI Story Doesn't Add Up
Seeking Alpha32 · bearishanalyst
Absci price target raised to $15 from $13 at BTIG
The Fly61 · neutralanalyst
Absci to Participate in Upcoming Investor Conferences
GlobeNewswire56 · neutralgeneral
Absci (ABSI) Q2 2026 Earnings Call Transcript
The Motley Fool56 · neutralearnings
Absci reports Q2 EPS (21c), consensus (20c)
The Fly52 · neutralearnings
Absci anticipates ABS-201 interim proof of concept data in 2H 2026, while guiding cash runway into 2H 2028
Seeking Alpha58 · neutralgeneral
Absci Corporation (ABSI) Q2 2026 Earnings Call Transcript
Seeking Alpha50 · neutralearnings
Absci Q2 Earnings Call Highlights
Yahoo Top56 · neutralearnings